Trials / Completed
CompletedNCT01367249
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
Efficacy and Safety of Bromfenac Ophthalmic Solution vs. Placebo for the Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 440 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an efficacy study of Bromfenac Ophthalmic Solution in cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bromfenac Ophthalmic Solution | Sterile ophthalmic solution |
| DRUG | Placebo | Sterile ophthalmic solution |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-07-01
- Completion
- 2011-12-01
- First posted
- 2011-06-07
- Last updated
- 2014-05-06
- Results posted
- 2014-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01367249. Inclusion in this directory is not an endorsement.